CorVel Corporation (NASDAQ: CRVL) — Form 10-Q Summary
Period clarification: The filing is for the three months ended June 30, 2021, CorVel’s first fiscal quarter of fiscal 2022—not 2020 Q1 as stated in the request metadata. The comparable quarter ended June 30, 2020. Financial statements are unaudited.
Business context
CorVel provides managed-care and medical cost-containment services, primarily for workers’ compensation, auto insurance, and group health claims. It reports one operating segment, managed care. Revenue comes from patient management services and network solutions services.
Financial performance
| Metric | Q1 FY2022 | Q1 FY2021 | Change |
|---|---|---|---|
| Revenue | $152.6 million | $129.6 million | +17.8% |
| Gross profit | $37.2 million | $26.5 million | +40.4% |
| Gross margin | 24.4% | 20.5% | +3.9 percentage points |
| General and administrative expense | $16.6 million | $15.6 million | +6.8% |
| Income before taxes | $20.6 million | $10.9 million | +88.3% |
| Net income | $16.8 million | $8.3 million | +102.9% |
| Diluted EPS | $0.92 | $0.46 | +100.0% |
| Operating cash flow | $14.5 million | $15.4 million | Down $1.0 million |
Patient management revenue rose 17.9% to $100.4 million; network solutions revenue rose 17.6% to $52.2 million. Management attributed growth to economic recovery from COVID-19 disruptions, higher TPA and related-services revenue, a 22% increase in new claims, and increased revenue per bill from enhanced bill-review programs. Cost of revenue increased 11.9%, including higher salaries as field-operations headcount rose 7%. The effective tax rate was 18.1%, versus 24.0% a year earlier.
Cash, liquidity, and debt
At June 30, 2021, cash and cash equivalents were $138.7 million, versus $139.7 million at March 31, 2021. Working capital was $114.6 million, compared with $106.5 million at fiscal year-end. The company reported no debt outstanding. Total liabilities were $192.9 million, including $53.6 million of lease liabilities.
Quarterly investing cash outflow was $6.5 million, mainly capital expenditures, compared with $3.6 million in the prior-year quarter. Financing cash outflow was $9.1 million, including $14.2 million of share repurchases and $5.1 million of stock-option proceeds. Operating cash flow declined year over year; management attributed the decrease primarily to the absence of a prior-year CARES Act payroll-tax deferral benefit.
Material changes, outlook, and risks
- Recovery and outlook: Revenue increased sequentially in the September and December 2020 quarters and the March and June 2021 quarters. Management expected this trend to continue during 2021, but provided no numerical financial guidance and cautioned that the trend was not assured.
- COVID-19 uncertainty: Management said the pandemic’s impact had decreased over time, while warning that economic disruption, unemployment, claim volumes, customer demand, vaccine effectiveness, and future outbreaks could adversely affect results, cash flows, and financial condition. The filing also says future-period results, including revenue, were expected to continue to be adversely impacted by COVID-19 and its economic effects.
- Capital allocation: The board expanded the lifetime share-repurchase authorization by 1 million shares in May 2021, to 38 million. CorVel repurchased 118,893 shares for approximately $14.2 million during the quarter; it subsequently repurchased another 63,984 shares for $8.8 million. Management said it could reduce or suspend repurchases if income or cash flow weakened.
- Tax deferrals: CorVel deferred $10.4 million of payroll-tax deposits under the CARES Act; half was due by the end of 2021 and half by the end of 2022.
- Facilities: The company said greater permanent remote work following COVID-19 led it to remove renewal periods from several leases. The remeasurement reduced lease assets and liabilities and had an immaterial income-statement impact. Approximately $5.4 million of additional operating lease commitments had not yet commenced.
- Other risks and contingencies: Risks include competition, changes in workers’ compensation claims and customer outsourcing, labor and benefit costs, technology and cybersecurity incidents, regulation, and litigation. Management said ordinary-course litigation was not expected to result in material payments. No material off-balance-sheet arrangements were reported, though certain indemnification obligations could arise.
Key facts for investors to verify
- Confirm the reporting period: this is the quarter ended June 30, 2021, not 2020 Q1.
- Assess whether the strong year-over-year growth reflects a durable improvement or a comparison against the COVID-affected June 2020 quarter; monitor claims, revenue per bill, and margins.
- Track cash conversion and working-capital movements, particularly accrued liabilities and the effect of payroll-tax repayments.
- Review the pace and prices of share repurchases, their effect on cash reserves, and remaining authorization.
- Monitor COVID-19-related demand risks, customer concentration or retention, cybersecurity exposure, and lease commitments.